AUROPHARMA (46)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE announces the Offer to Buy (Buyback) acquisition window schedule for Aurobindo Pharma Ltd (AUROPHARMA), open from April 23 to April 29, … | |||||||||||||||
BSE announces the Offer to Buy (Buyback) acquisition window schedule for Aurobindo Pharma Ltd (AUROPHARMA), open from April 23 to April 29, 2026, at an offer price of Rs. 1475 per share for up to 54,23,728 equity shares.
| |||||||||||||||
BSE notifies opening of buyback offer by Aurobindo Pharma Limited to repurchase up to 54,23,728 equity shares at Rs.1,475 per share via … | |||||||||||||||
BSE notifies opening of buyback offer by Aurobindo Pharma Limited to repurchase up to 54,23,728 equity shares at Rs.1,475 per share via tender offer route, aggregating up to Rs.800 crore, open from April 23 to April 29, 2026.
| |||||||||||||||
BSE/ICCL announces the settlement calendar for Aurobindo Pharma Limited buyback acquisition window running from April 23 to April 29, 2026, … | |||||||||||||||
BSE/ICCL announces the settlement calendar for Aurobindo Pharma Limited buyback acquisition window running from April 23 to April 29, 2026, with settlement date of May 7, 2026.
| |||||||||||||||
NSE Clearing imposes 15% additional exposure margin on 20 securities in equity derivatives where top 10 clients exceed 20% of MWPL, … | |||||||||||||||
NSE Clearing imposes 15% additional exposure margin on 20 securities in equity derivatives where top 10 clients exceed 20% of MWPL, effective May 4, 2026 after April expiry.
| |||||||||||||||
BSE notifies trading members that Aurobindo Pharma Ltd has fixed April 17, 2026 as the record date for determining shareholder eligibility … | |||||||||||||||
BSE notifies trading members that Aurobindo Pharma Ltd has fixed April 17, 2026 as the record date for determining shareholder eligibility to participate in its equity share buyback offer.
| |||||||||||||||
NSE Clearing Limited releases the revised list of securities available for transactions under the Securities Lending and Borrowing Scheme … | |||||||||||||||
NSE Clearing Limited releases the revised list of securities available for transactions under the Securities Lending and Borrowing Scheme (SLBS) for April 2026, containing over 175+ eligible securities. | |||||||||||||||
NSE circular specifying Market Wide Position Limits (MWPL) and trading limits for TM, FII/FPI Category I & II, and Mutual Funds across F&O … | |||||||||||||||
NSE circular specifying Market Wide Position Limits (MWPL) and trading limits for TM, FII/FPI Category I & II, and Mutual Funds across F&O eligible securities effective March 2026.
| |||||||||||||||
NSE Clearing Limited imposes additional exposure margin of 15% in equity derivatives segment on 21 securities where top 10 clients account … | |||||||||||||||
NSE Clearing Limited imposes additional exposure margin of 15% in equity derivatives segment on 21 securities where top 10 clients account for more than 20% of MWPL, effective April 1, 2026.
| |||||||||||||||
NSE revises the strike scheme for stock options, updating step values and number of strikes for multiple securities effective April 1, 2026. … | |||||||||||||||
NSE revises the strike scheme for stock options, updating step values and number of strikes for multiple securities effective April 1, 2026. Members must load updated contract.gz file before trading.
| |||||||||||||||
NSE Clearing Limited publishes the revised list of securities available for transactions under the Securities Lending & Borrowing Scheme … | |||||||||||||||
NSE Clearing Limited publishes the revised list of securities available for transactions under the Securities Lending & Borrowing Scheme (SLBS) for the month of March 2026, comprising hundreds of eligible symbols. | |||||||||||||||